In English | En español
Questions About Cancer? 1-800-4-CANCER

Find News Releases

Search For:
Between these dates:

All News Releases

New University of Kentucky study shows potential for targeting aggressive breast cancers
NCI Cancer Center News
(Posted: 02/12/2014) - A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou may provide an effective approach for treating triple-negative breast cancer.

Fred Hutchinson researchers find that smoking is linked with increased risk of most common type of breast cancer
NCI Cancer Center News
(Posted: 02/11/2014) - Young women – current or recent smokers who have smoked a pack a day for a decade or more – have a significantly increased risk of developing the most common type of breast cancer.

Dana-Farber researchers report that a normal enzyme aids a mutant one to fuel blood cancer’s growth
NCI Cancer Center News
(Posted: 02/11/2014) - A normal enzyme called SYK pairs with FLT3, the most commonly mutated enzyme found in acute myelogenous leukemia, to promote progression of the cancer and its resistance to treatment with FLT3-blocking drugs, which may explain relatively poor results in clinical studies.

NYU scientists note weakness of a common cancer gene
NCI Cancer Center News
(Posted: 02/11/2014) - NYU Langone Medical Center researchers have found a biological weakness in the workings of the most commonly mutated gene involved in human cancers, known as mutant K-Ras, which they say can be exploited by drug chemotherapies to thwart tumor growth.

NIH study finds regular aspirin use may reduce ovarian cancer risk
NCI Press Release
(Posted: 02/06/2014) - Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. However, further research is needed before clinical recommendations can be made. The study was published Feb. 6, 2014, in the Journal of the National Cancer Institute.
View the article in Spanish

University of Kansas researchers establish potential benefits of high-dose vitamin C for ovarian cancer patients
NCI Cancer Center News
(Posted: 02/06/2014) - University of Kansas Medical Center researchers say a pilot clinical trial shows potential benefits of complementary treatment with high-dose vitamin C for ovarian cancer patients.

Dana-Farber researchers find that marker may predict response to ipilimumab in advanced melanoma
NCI Cancer Center News
(Posted: 02/05/2014) - Dana-Farber researchers found that in patients with advanced melanoma using the immunotherapy ipilimumab, presence of higher levels of the protein VEGF in the blood was associated with a poorer response.

Albert Einstein researchers find that a chemical stem cell signature predicts treatment response for AML
NCI Cancer Center News
(Posted: 02/04/2014) - Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical “signature” in blood-forming stem cells that predicts whether patients with acute myeloid leukemia will respond to chemotherapy.

Roswell Park researchers findings on key gene related to cancer metastasis
NCI Cancer Center News
(Posted: 02/04/2014) - Roswell Park researchers report that the loss of these two genes and associated protein products leads to early prostate cancer.

Stanford researchers find that oral anti-fungal drug can treat skin cancer in patients
NCI Cancer Center News
(Posted: 02/04/2014) - A new study shows that a common anti-fungal treatment called itraconazole may be useful in treating basal cell carcinoma -- the most common form of skin cancer.

< Previous  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  Next >